Loading...

Danaher Corporation

DHR-PBNYSE
Healthcare
Medical - Diagnostics & Research
$1261.26
$-9.94(-0.78%)

Danaher Corporation (DHR-PB) Stock Competitors & Peer Comparison

See (DHR-PB) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Diagnostics & Research Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
DHR-PB$1,261.26-0.78%916.8B146.01$8.64+0.56%
TMO$499.99+3.35%188.8B28.96$17.27+0.33%
DHR$211.80+3.87%151.6B44.94$4.71+0.56%
IDXX$645.55+1.97%51.6B53.66$12.03N/A
A$121.63+3.82%34.6B29.96$4.06+0.81%
IQV$191.15+3.11%32.5B27.74$6.89N/A
MTD$1,321.45+3.40%27.2B33.54$39.37N/A
NTRA$165.60+2.25%22.7B-86.70-$1.91N/A
DGX$180.23-1.90%20.2B21.59$8.35+1.72%
WAT$302.19+4.05%18B27.25$11.09N/A
Showing 1 to 10 of 89 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

DHR-PB vs TMO Comparison August 2025

DHR-PB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DHR-PB stands at 916.8B. In comparison, TMO has a market cap of 188.8B. Regarding current trading prices, DHR-PB is priced at $1,261.26, while TMO trades at $499.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DHR-PB currently has a P/E ratio of 146.01, whereas TMO's P/E ratio is 28.96. In terms of profitability, DHR-PB's ROE is +0.07%, compared to TMO's ROE of +0.13%. Regarding short-term risk, DHR-PB is less volatile compared to TMO. This indicates potentially lower risk in terms of short-term price fluctuations for DHR-PB.Check TMO's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;